Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia

Clinical trial NCT06971913 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06971913
Sponsor: Peking University People's Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

SLE (Systemic Lupus)CMV

Start date: 2025-05-20
Primary completion: 2025-09-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.